Search
Perrigo Company PLC
PRGOAdd to Watchlist
13.560USD
+0.080+0.59%
Close 09-17 16:00（ET）
1.88BMarket Cap
LossP/E TTM
After-hours 16:10 (ET)13.560USD0.000
After-hours 16:10 (ET)Perrigo Company PLC (PRGO) Revenue Performance
Updated: Jun 27, 2026Last year, Perrigo Company PLC generated 270.90M USD for its biggest-performing segment, Contract Manufacturing. The United States made the largest contribution, accounting for 2.54B USD last year. For the latest quarter, Perrigo Company PLC reported the revenue of 217.80M USD for the period ending 2025-12-31, which came from the top-performing segment, Upper respiratory. United States contributed the highest revenue, at 626.40M USD.
By Business
Revenue
Proportion
Annual
Annual
Quarterly
Contract Manufacturing
Upper respiratory
Pain and sleep-aids
Skincare and personal hygiene
Nutrition
Digestive health
Healthy lifestyle
Oral self-care
Vitamins, minerals, and supplements
Other
Women's Health
Animal health
Unallocated
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Contract Manufacturing
270.90M(100.00%)
306.20M(100.00%)
--(--)
--(--)
--(--)
262.40M(6.03%)
286.80M(6.90%)
300.50M(100.00%)
Upper respiratory
--(--)
--(--)
858.30M(18.44%)
823.20M(18.49%)
709.30M(17.14%)
760.90M(17.49%)
806.10M(19.39%)
--(--)
Pain and sleep-aids
--(--)
--(--)
619.30M(13.30%)
595.20M(13.37%)
607.20M(14.67%)
624.90M(14.36%)
558.80M(13.44%)
--(--)
Skincare and personal hygiene
--(--)
--(--)
568.70M(12.22%)
620.00M(13.93%)
613.50M(14.82%)
552.40M(12.70%)
562.90M(13.54%)
--(--)
Nutrition
--(--)
--(--)
563.20M(12.10%)
520.40M(11.69%)
401.90M(9.71%)
388.30M(8.93%)
395.30M(9.51%)
--(--)
Digestive health
--(--)
--(--)
546.30M(11.73%)
517.00M(11.61%)
513.50M(12.41%)
497.80M(11.44%)
456.30M(10.98%)
--(--)
Healthy lifestyle
--(--)
--(--)
537.40M(11.54%)
425.30M(9.55%)
477.00M(11.53%)
517.80M(11.90%)
529.90M(12.75%)
--(--)
Oral self-care
--(--)
--(--)
415.40M(8.92%)
401.50M(9.02%)
407.70M(9.85%)
386.00M(8.87%)
162.90M(3.92%)
--(--)
Vitamins, minerals, and supplements
--(--)
--(--)
203.00M(4.36%)
219.70M(4.94%)
249.10M(6.02%)
228.00M(5.24%)
208.80M(5.02%)
--(--)
Other
--(--)
--(--)
177.40M(3.81%)
184.90M(4.15%)
159.50M(3.85%)
132.10M(3.04%)
145.20M(3.49%)
--(--)
Women's Health
--(--)
--(--)
166.60M(3.58%)
144.20M(3.24%)
--(--)
--(--)
--(--)
--(--)
Animal health
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
43.70M(1.05%)
--(--)
Unallocated
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
United States
Europe
All other countries
Ireland
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
United States
2.54B(59.72%)
2.65B(60.58%)
2.92B(62.65%)
2.87B(64.47%)
2.57B(62.00%)
2.58B(63.08%)
2.36B(60.99%)
3.10B(65.48%)
3.27B(66.16%)
3.35B(63.50%)
3.30B(71.76%)
3.29B(81.06%)
2.87B(91.10%)
Europe
1.62B(38.00%)
1.60B(36.69%)
1.62B(34.85%)
1.47B(33.12%)
1.39B(33.66%)
1.35B(33.04%)
1.34B(34.52%)
1.35B(28.48%)
1.31B(26.55%)
1.49B(28.27%)
613.60M(13.33%)
--(--)
--(--)
All other countries
96.70M(2.27%)
119.50M(2.73%)
116.30M(2.50%)
107.30M(2.41%)
179.80M(4.34%)
158.60M(3.88%)
173.80M(4.49%)
285.80M(6.04%)
330.30M(6.68%)
345.50M(6.54%)
342.70M(7.44%)
622.50M(15.33%)
279.40M(8.87%)
Ireland
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
30.40M(0.61%)
89.10M(1.69%)
344.00M(7.47%)
146.70M(3.61%)
1.00M(0.03%)